Skip to main content
Frontiers in Oncology logoLink to Frontiers in Oncology
. 2025 Sep 12;15:1697346. doi: 10.3389/fonc.2025.1697346

Correction: CS Ratio is an immune-related prognostic biomarker for cervical cancer

Peiqin Shi 1,, Wenwen Zhang 2,, Qingqing Yao 3, Zhanna Yuan 1,4, Jiaqi Wang 1, Ziye Yang 3, Pengpeng Qu 1,3,5,*
PMCID: PMC12465277  PMID: 41018079

Authors “Peiqin Shi” and “Wenwen Zhang” were erroneously omitted as equal contributing author.

The original version of this article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.


Articles from Frontiers in Oncology are provided here courtesy of Frontiers Media SA

RESOURCES